Correction: Iqbal et al. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. Materials 2021, 14, 3155
Haroon Iqbal, Anam Razzaq, Bushra Uzair, Noor Ul Ain, Shamaila Sajjad, Norah Ayidh Althobaiti, Aishah Eid Albalawi, Bouzid Menaa, Muhammad Haroon, Muslim Khan, Naveed Ullah Khan, Farid Menaa

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Iqbal H. Razzaq A. Uzair B. Ain N.U. Sajjad S. Althobaiti N.A. Albalawi A.E. Menaa B. Haroon M. Khan M. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice Materials 202114315510.3390/ma 1412315534201266 PMC 8229371 · doi ↗ · pubmed ↗
